atai Life Sciences to Participate in November Investor Events & Healthcare Conferences

Rhea-AI Summary

atai Life Sciences (Nasdaq: ATAI) will participate in several investor events and healthcare conferences in November 2022. Key events include:

• Financial Times Pharma and Biotech Summit on November 9, 2022, 9:55 a.m. ET
• Credit Suisse Annual Healthcare Conference on November 9, 2022, 4:35 p.m. ET
• HLTH in Las Vegas on November 14, 2022, 7:20 p.m. ET
• Jefferies Healthcare Conference on November 16, 2022, 8:00 a.m. GMT
• CNS Summit in Boca Raton on November 19, 2022, 12:00 p.m. ET

Archived webcasts will be available on the company's website for 90 days.

NEW YORK and BERLIN, Nov. 01, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the following investor events & healthcare conferences:

• Financial Times Pharma and Biotech Summit in London
  Format: Industry Panel
  Date and Time: Wednesday, November 9^th, 9:55 a.m. – 10:40 a.m. ET
  Conference link: Financial Times’ Pharma and Biotech Summit

• Credit Suisse Annual Healthcare Conference in Southern California
  Format: Fireside Chat
  Date and Time: Wednesday, November 9^th, 4:35 p.m. – 6:35 p.m. ET
  Conference link: Credit Suisse Annual Healthcare Conference

• HLTH in Las Vegas
  Format: Industry Panel
  Date and Time: Monday, November 14^th, 7:20 p.m. - 8:00 p.m. ET
  Conference link: HLTH

• Jefferies Healthcare Conference in London
  Format: Fireside Chat
  Date and Time: Wednesday, November 16^th, 8:00 a.m. – 8:30 a.m. GMT
  Conference link: Jefferies London Healthcare Conference

• Collaborating for Novel Solutions (CNS) Summit in Boca Raton, Florida
  Format: Keynote Industry Panel
  Date and Time: Saturday, November 19^th, 12 p.m. – 12:30 p.m. ET
  Conference link: Collaborating for Novel Solutions Summit

Certain events will have archived webcasts available in the Events section of atai’s website at https://www.atai.life, where they will be available for up to 90 days.

About atai Life Sciences
atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, atai is dedicated to acquiring, incubating, and efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders.

By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines across its companies to achieve clinically meaningful and sustained behavioral change in mental health patients.

atai's vision is to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit www.atai.life

Contact Information

Investor Contact:
Stephen Bardin
Chief Financial Officer
Email: IR@atai.life

Media Contact:
Allan Malievsky
Senior Director of External Affairs
Email: PR@atai.life 

FAQ

What is atai Life Sciences' schedule for November 2022?

atai Life Sciences will participate in multiple events on November 9, 14, 16, and 19, 2022.

When is the Financial Times Pharma and Biotech Summit?

The Financial Times Pharma and Biotech Summit is on November 9, 2022, from 9:55 a.m. to 10:40 a.m. ET.

What event will atai Life Sciences attend on November 14, 2022?

atai will attend the HLTH conference in Las Vegas on November 14, 2022, at 7:20 p.m. ET.

Where can I find archived webcasts of atai Life Sciences' events?

Archived webcasts of atai's events will be available on their website for up to 90 days.

What is the focus of atai Life Sciences as a biopharmaceutical company?

atai Life Sciences focuses on transforming the treatment of mental health disorders.